Aspirin News and Research

RSS

Aspirin also known as acetylsalicylic acid is a salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication. Aspirin also has an antiplatelet, or "anti-clotting", effect and is used in long-term, low doses to prevent heart attacks, strokes and blood clot formation in people at high risk for developing blood clots. It has also been established that low doses of aspirin may be given immediately after a heart attack to reduce the risk of another heart attack or of the death of cardiac tissue.

Mediterranean diet vs. Ultra-processed foods: Impact on frailty in older adults

Researchers evaluate whether ultra-processed food and Mediterranean diet scores were associated with frailty and cardiometabolic disease in older adults.

6 Sep 2024

Edoxaban monotherapy superior to dual therapy in patients with high-risk AF and stable CAD

Edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as long-term antithrombotic therapy, in patients with high-risk atrial fibrillation (AF) and stable coronary artery disease (CAD), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

1 Sep 2024

Triple-pill combination GMRx2 outperforms standard care in lowering blood pressure

New research shows that a treatment plan based on novel combination of low doses of three anti-hypertensive drugs in a single pill - known as GMRx2 - was superior to a high-quality standard care treatment plan at lowering blood pressure in patients with uncontrolled hypertension.

1 Sep 2024

Research suggests flexible approach to antiplatelet management after drug-eluting stent implantation

Among patients undergoing non-cardiac surgery more than 1 year after coronary drug-eluting stent (DES) implantation, there was no difference with respect to ischaemic outcomes or major bleeding between perioperative aspirin monotherapy and receiving no antiplatelet therapy, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

1 Sep 2024

Routine lipoprotein(a) testing recommended for all adults

Heart experts say that everyone should have their levels of lipoprotein (a) (Lp(a) measured routinely at least once in life, following research from one of the most populous EU countries, Poland, that shows how common high levels of Lp(a) are in the general population.

29 Aug 2024

Maternal gut bacteria linked to changes in fetal brain metabolism

The impact of Bifidobacterium breve's presence in the maternal gut during pregnancy on fetal brain metabolism.

23 Aug 2024

Revolutionary platelet score offers better risk assessment for heart attacks

Platelets are circulating cell fragments known to clump up and form blood clots that stop bleeding in injured vessels.

20 Aug 2024

Study finds aspirin reduces colon cancer risk, with benefits varying by lifestyle factors

Aspirin can reduce colorectal cancer risk, but its effectiveness varies based on lifestyle factors such as diet, BMI, and smoking. Personalized recommendations are crucial to identify those who would benefit most from aspirin use.

7 Aug 2024

Uncovering hidden drug benefits through protein mapping

Fewer side effects, improved chances of healing: the goal of precision medicine is to provide patients with the most individualized treatment possible. This requires a precise understanding of what is happening at the cellular level. For the first time, researchers at the Technical University of Munich (TUM) have now succeeded in mapping the interactions of 144 active substances with around 8,000 proteins. The results could help to identify previously unknown potential benefits of existing drugs.

2 Aug 2024

Aspirin may lower colorectal cancer risk for people with unhealthy lifestyles

Regular aspirin may help lower risk of colorectal cancer in people with greater lifestyle-related risk factors for the disease, according to a study led by researchers at Mass General Brigham.

1 Aug 2024

Low-dose aspirin does not affect the progression of age-related hearing loss

The effect of daily low-dose aspirin versus placebo on the progression of age-related hearing loss in healthy older adults.

30 Jul 2024

Researchers to trial ground-breaking screening test for pre-eclampsia

Researchers are to trial a ground-breaking screening test for pre-eclampsia, a potentially life-threatening condition affecting pregnant women and their unborn babies.

29 Jul 2024

Low-dose aspirin shows promise in treating flu-related vascular inflammation during pregnancy

A world-first study has found low-dose aspirin may treat flu-induced blood vessel inflammation, creating better blood flow to the placenta during pregnancy.

2 Jul 2024

Atogepant may decrease the risk of developing rebound headache in people with migraine

A drug used to prevent migraine may also be effective in people with migraine who experience rebound headaches, according to a new study published in the June 26, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

26 Jun 2024

Study reveals high rates of aspirin use for CVD prevention among older adults

A survey representing about 150 million adults annually suggests that aspirin use for primary prevention of cardiovascular disease (CVD) remains prevalent among older adults, contrary to recommendations from the American College of Cardiology and the American Heart Association.

24 Jun 2024

Study: Anti-inflammatory drug celecoxib benefits PIK3CA-mutated colon cancer patients

An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory drug, after surgery lived significantly longer and had longer disease-free survival compared to those without the mutation.

18 Jun 2024

American Heart Association launches initiative to tackle recurrent pericarditis

About 40,000 people in the United States experience recurrent pericarditis, or inflammation of the sac-like structure that protects the heart, which can cause chest pain and may lead to fluid buildup around the heart muscle.

17 Jun 2024

Coronary arterial inflammation linked to high cardiac event risk even without CAD

Researchers in The Lancet highlight coronary arterial inflammation's role in increasing major adverse cardiac events and cardiovascular deaths, irrespective of coronary artery disease presence.

3 Jun 2024

Low-dose aspirin can reduce inflammatory responses to sleep restriction

A new study to be presented at the SLEEP 2024 annual meeting found that low-dose acetylsalicylic acid, also known as aspirin, can reduce inflammatory responses to sleep restriction.

3 Jun 2024

Stress and pain linked to worse outcomes in HER2-positive breast cancer patients

Secondary analyses of a phase 3 clinical trial have revealed that breast cancer patients who reported high levels of pain and stress were more likely than their study peers to experience worse invasive disease-free survival (iDFS) and worse overall survival (OS).

31 May 2024

Aspirin News and Research

Mediterranean diet vs. Ultra-processed foods: Impact on frailty in older adults

Edoxaban monotherapy superior to dual therapy in patients with high-risk AF and stable CAD

Triple-pill combination GMRx2 outperforms standard care in lowering blood pressure

Research suggests flexible approach to antiplatelet management after drug-eluting stent implantation

Routine lipoprotein(a) testing recommended for all adults

Maternal gut bacteria linked to changes in fetal brain metabolism

Revolutionary platelet score offers better risk assessment for heart attacks

Study finds aspirin reduces colon cancer risk, with benefits varying by lifestyle factors

Uncovering hidden drug benefits through protein mapping

Aspirin may lower colorectal cancer risk for people with unhealthy lifestyles

Low-dose aspirin does not affect the progression of age-related hearing loss

Researchers to trial ground-breaking screening test for pre-eclampsia

Low-dose aspirin shows promise in treating flu-related vascular inflammation during pregnancy

Atogepant may decrease the risk of developing rebound headache in people with migraine

Study reveals high rates of aspirin use for CVD prevention among older adults

Study: Anti-inflammatory drug celecoxib benefits PIK3CA-mutated colon cancer patients

American Heart Association launches initiative to tackle recurrent pericarditis

Coronary arterial inflammation linked to high cardiac event risk even without CAD

Low-dose aspirin can reduce inflammatory responses to sleep restriction

Stress and pain linked to worse outcomes in HER2-positive breast cancer patients

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News